WINDTREE THERAPEUTICS INC (46)

Browse by Contract Category

Contracts

Form of Inducement Letter (Filed With SEC on January 26, 2023)
Form of New Warrant (Filed With SEC on January 26, 2023)
Amended and Restated License, Development and Commercialization Agreement, by and among Lees Pharmaceutical (HK) Ltd., Zhaoke Pharmaceutical (Hefei) Co. Ltd., and Windtree... (Filed With SEC on November 14, 2022)
Employment Agreement by and between Windtree and Diane Carman, dated as of July 1, 2021 (Filed With SEC on March 31, 2022)
Agreement for Scientific Collaboration between Universita degli Studi di Milano-Bicocca and CVie Therapeutics Ltd, a wholly-owned subsidiary of the Registrant, dated March 19, 2021 (Filed With SEC on May 13, 2021)
Description of Securities (Filed With SEC on March 29, 2021)
Form of Warrant Agency Agreement (Filed With SEC on March 24, 2021)
Form of Warrant (Filed With SEC on March 24, 2021)
Underwriting Agreement, dated March 23, 2021, by and among the Company and Oppenheimer & Co. Inc., as representative for the several underwriters named therein (Filed With SEC on March 24, 2021)
2020 Equity Incentive Plan (Filed With SEC on December 31, 2020)
Amended and Restated Supply Agreement, dated as of December 3, 2004, by and between Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) and Laboratorios Del Dr.... (Filed With SEC on November 16, 2020)
Collaboration Agreement dated as of October 10, 2014, by and between Battelle Memorial Institute and Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) (Filed With SEC on November 16, 2020)
Project Financing Agreement, dated August 12, 2020, by and between Windtree and Lees Pharmaceutical (HK) Ltd (Filed With SEC on November 16, 2020)
Amended and Restated Sublicense and Collaboration Agreement, dated December 3, 2004, by and between Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) and... (Filed With SEC on November 16, 2020)
Separation Agreement by and between Windtree and John A. Tattory, dated as of July 29, 2020 (Filed With SEC on August 14, 2020)
Employment Agreement by and between the Company and John Hamill dated as of July 20, 2020 (Filed With SEC on July 23, 2020)
Form of Warrant Agency Agreement between Windtree Therapeutics, Inc. and Continental Stock Transfer and Trust Company (Filed With SEC on May 22, 2020)
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to the Registration Statement on Form S-1, filed on January 27, 2020, as amended (Filed With SEC on May 22, 2020)
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 19, 2020)
Form of Underwriting Agreement (Filed With SEC on May 19, 2020)
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 14, 2020)
Form of Series I Amendment dated May 6, 2020 (Filed With SEC on May 7, 2020)
Loan Agreement dated March 17, 2020, between CVie Therapeutics, Lees Pharmaceutical Holdings Limited, and O-Bank Co., Ltd (Filed With SEC on May 6, 2020)
Binding Term Sheet dated March 18, 2020, between Windtree and Lees Pharmaceutical (HK) LTD (Filed With SEC on May 6, 2020)
Form of Series I Warrant Amendment dated May 6, 2020 to the Series I Warrant dated December 6, 2019 (Filed With SEC on May 6, 2020)
Form of Warrant Agreement between Windtree Therapeutics, Inc. and Continental Stock Transfer and Trust Company (Filed With SEC on May 6, 2020)
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 6, 2020)
Form of Underwriting Agreement (Filed With SEC on May 6, 2020)
Amendment No. 1 to Payment Restructuring Agreement effective December 7, 2018, between Windtree and Battelle Memorial Institute (Filed With SEC on May 6, 2020)
Form of Series F Warrant Amendment dated April 24, 2020 (Filed With SEC on April 29, 2020)
Note dated April 20, 2020, between Windtree Therapeutics, Inc. and Newtek Small Business Finance, LLC (Filed With SEC on April 24, 2020)
Description of Securities (Filed With SEC on April 3, 2020)
Form of Non-Employee Director Option Agreement under Windtrees 2011 Long-Term Incentive Plan (Filed With SEC on April 3, 2020)
Amendment to No. 1 dated February 20, 2020 to the Securities Purchase Agreement dated December 6, 2019 by and among Windtree and the purchasers party thereto (Filed With SEC on April 3, 2020)
Employment Agreement dated March 1, 2020, between Windtree and Eric Curtis (Filed With SEC on April 3, 2020)
Form of Registration Rights Agreement, dated December 6, 2019 by and among the Company and the purchasers party thereto (Filed With SEC on December 9, 2019)
Form of Securities Purchase Agreement, dated December 6, 2019 by and among the Company and the purchasers party thereto (Filed With SEC on December 9, 2019)
Form of Series I Warrant (Filed With SEC on December 9, 2019)
Loan Agreement (Filed With SEC on October 28, 2019)
Shareholder Loan Agreement dated April 24, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
Loan Agreement dated October 25, 2018, between CVie Therapeutics, Lees Pharmaceutical Holdings Limited, and O-Bank Co., Ltd (Filed With SEC on April 16, 2019)
Form of Indemnification Agreement between Windtree and certain named directors (Filed With SEC on April 16, 2019)
Shareholder Loan Agreement dated September 20, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
Shareholder Loan Agreement dated October 26, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
Shareholder Loan Agreement dated November 16, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
Form of Series E Warrant dated December 11, 2018 (Filed With SEC on April 16, 2019)